<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1357">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01740700</url>
  </required_header>
  <id_info>
    <org_study_id>12-002</org_study_id>
    <nct_id>NCT01740700</nct_id>
  </id_info>
  <brief_title>Zenith® p-Branch™ OTS Multicenter Study</brief_title>
  <official_title>Zenith® p-Branch™ Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the Zenith® p-Branch™ OTS Multicenter Study is to provide an early clinical
      experience and evaluate the safety and effectiveness of the Zenith® p-Branch™ in the
      treatment of pararenal or juxtarenal abdominal aortic aneurysms (AAA).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Technical success</measure>
    <time_frame>Within 30 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Technical success is defined as successful access and deployment of the graft and patency of the vessels targeted by fenestrations.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <arm_group>
    <arm_group_label>p-Branch™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>p-Branch™</intervention_name>
    <description>Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta.</description>
    <arm_group_label>p-Branch™</arm_group_label>
    <other_name>Endovascular graft</other_name>
    <other_name>Endovascular stent</other_name>
    <other_name>Stent-graft</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pararenal or juxtarenal AAA ≥5.0 cm in diameter or 2 times the normal aortic diameter

          -  Pararenal or juxtarenal AAA with history of growth ≥0.5 cm/year

          -  Saccular aneurysm with aortic diameter greater than 1.5 times the normal aortic
             diameter that is deemed to be at risk for rupture based upon physician interpretation

        Exclusion Criteria:

          -  Age &lt;18 years

          -  Life expectancy &lt;2 years

          -  Pregnant, breast-feeding, or planning on becoming pregnant within 60 months

          -  Inability or refusal to give informed consent by the patient or a legally authorized
             representative

          -  Unwilling or unable to comply with the follow-up schedule

          -  Simultaneously participating in another investigative device or drug study. (The
             patient must have completed the primary endpoint of any previous study at least 30
             days prior to enrollment in this study.)

          -  Additional medical restrictions as specified in the Clinical Investigation Plan

          -  Additional anatomical restrictions as specified in the Clinical Investigation Plan
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark A Farber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zach Dawson, PhD</last_name>
    <phone>765-463-7537</phone>
    <email>zdawson@medinst.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Beck, MD</last_name>
      <phone>352-273-5484</phone>
      <email>adam.beck@surgery.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Community Heart and Vascular Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46250</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Methodist Hospital of Indiana</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andres Fajardo, MD</last_name>
      <phone>317-274-4966</phone>
      <email>afajardo@iupui.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical School</name>
      <address>
        <city>Worster</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andres Schanzer, MD</last_name>
      <phone>508-856-5599</phone>
      <email>Andres.Schanzer@umassmemorial.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustavo Oderich, MD</last_name>
      <phone>507-284-1575</phone>
      <email>Oderich.gustavo@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barnes-Jewish Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Sanchez, MD</last_name>
      <phone>314-362-7408</phone>
      <email>sanchezl@wudosis.wustl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vito Mantese, MD</last_name>
      <phone>314-251-6840</phone>
      <email>vito.mantese@mercy.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Fairman, MD</last_name>
      <phone>215-614-0308</phone>
      <email>ron.fairman@uphs.upenn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Timaran, MD</last_name>
      <phone>214-645-0545</phone>
      <email>timaran1@msn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alan Lumsden, MD</last_name>
      <phone>713-441-5200</phone>
      <email>ablumsden@tmhs.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 12, 2014</lastchanged_date>
  <firstreceived_date>October 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Abdominal aortic aneurysm</keyword>
  <keyword>Endovascular</keyword>
  <keyword>Fenestration</keyword>
  <keyword>Juxtarenal</keyword>
  <keyword>Off-the-shelf</keyword>
  <keyword>Pararenal</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
